Castle Biosciences to Present at Upcoming Investor Conferences

Business Wire

Wed, Nov 8, 2023, 1:00 PM2 min read

In this article:

FRIENDSWOOD, Texas, November 08, 2023--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Company’s executive management is scheduled to present a company overview at the following investor conferences later this month:

Stephens Annual Investment Conference on Nov. 15, 2023, at 11:00 a.m. Eastern Time.
Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Nov. 16, 2023, at 9:00 a.m. Eastern time.
Piper Sandler 35th Annual Healthcare Conference on Nov. 28, 2023, at 12:30 p.m. Eastern time.

Live audio webcasts of the Company’s presentations will be available by visiting Castle Biosciences’ website at https://ir.castlebiosciences.com/events-presentations/default.aspx. Replays of the webcasts will be available following the conclusion of the broadcasts.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231108949553/en/

Contacts

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com

Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Motley Fool•1d ago
Fed's Powell, jobs report and Apple will rock markets this week
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
TheStreet•6h ago
California Fast-Food Chains Are Now Serving Sticker Shock
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
The Wall Street Journal•8h ago
Former House Speaker Nancy Pelosi Nearly Tripled the S&P 500's Returns in 2023: Here Are the Stocks She's Been Buying
Nancy Pelosi's husband Paul Pelosi uses an investing strategy that lowers upfront costs.
Motley Fool•2h ago
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
The $50 million purchase could turn into Nvidia's biggest investment.
Motley Fool•23h ago
2 Incredibly Cheap Dividend Stocks to Buy Now
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
Motley Fool•14h ago
A Once-in-a-Generation Investment Opportunity: 1 Artificial Intelligence (AI) Growth Stock to Buy Now and Hold For a Decade
AI could generate trillions of dollars over the next ten years. One company is already an early winner of this windfall.
Motley Fool•3h ago
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
Motley Fool•2h ago
In 4 Days, Philip Morris Stock Becomes an Even Better Investment
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Motley Fool•16h ago
Are You Saving Enough To Be In The Top 3% Of Retirees? Here's How Much You Need
Retirement savings play a crucial role in securing financial stability in your golden years. For those aiming high, being in the top 3% of retirees in terms of savings enhances comfort and offers greater financial freedom. Using data from the Federal Reserve's Survey of Consumer Finances, a 2024 survey by the Employee Benefit Research Institute, reveals that individuals with over $1 million in retirement accounts rank in the top 3% of retirees. Only 3.2% of retirees have surpassed the $1 million
Benzinga•2d ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Castle Biosciences to Present at Upcoming Investor Conferences

Recommended Stories

Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead

Fed's Powell, jobs report and Apple will rock markets this week

California Fast-Food Chains Are Now Serving Sticker Shock

Former House Speaker Nancy Pelosi Nearly Tripled the S&P 500's Returns in 2023: Here Are the Stocks She's Been Buying

Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves

2 Incredibly Cheap Dividend Stocks to Buy Now

A Once-in-a-Generation Investment Opportunity: 1 Artificial Intelligence (AI) Growth Stock to Buy Now and Hold For a Decade

3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street

In 4 Days, Philip Morris Stock Becomes an Even Better Investment

Are You Saving Enough To Be In The Top 3% Of Retirees? Here's How Much You Need